 | • レポートコード：QYR9ST03202 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、免疫腫瘍学の世界市場について調査・分析し、免疫腫瘍学の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（免疫チェックポイント阻害剤、モノクローナル抗体、サイトカインベースの免疫療法、癌ワクチン、CAR-T細胞療法）、用途別（病院、薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の免疫腫瘍学市場動向 ・主要企業別マーケットシェア ・免疫腫瘍学の種類別市場規模2014-2019 （免疫チェックポイント阻害剤、モノクローナル抗体、サイトカインベースの免疫療法、癌ワクチン、CAR-T細胞療法） ・免疫腫瘍学の用途別市場規模2014-2019 （病院、薬局、オンライン薬局） ・免疫腫瘍学の北米市場：主要企業・種類別/用途別市場規模 ・免疫腫瘍学のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・免疫腫瘍学の中国市場：主要企業・種類別/用途別市場規模 ・免疫腫瘍学の日本国内市場：主要企業・種類別/用途別市場規模 ・免疫腫瘍学の東南アジア市場：主要企業・種類別/用途別市場規模 ・免疫腫瘍学のインド市場：主要企業・種類別/用途別市場規模 ・免疫腫瘍学の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Amgen, Inc、AstraZeneca, Plc、Bristol-Myers Squibb、Celgene Corporation、Eli Lilly and Company、Merck & Co.、Hoffmann-La Roche AG、Johnson & Johnson、Novartis International AG、AbbVie、Pfizer Inc.、Sanofi S.A.、EMD Serono、Gilead Sciences Inc.、Prometheus Therapeutics & Diagnostics、Aduro BioTech、Galena Biopharma、Bavarian Nordic、Celldex Therapeutics、ImmunoCellular Therapeutics、Incyte） ・免疫腫瘍学の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body’s own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.In 2018, the global Immuno-Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Immuno-Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immuno-Oncology development in United States, Europe and China.
The key players covered in this study
Amgen, Inc
AstraZeneca, Plc
Bristol-Myers Squibb
Celgene Corporation
Eli Lilly and Company
Merck & Co.
Hoffmann-La Roche AG
Johnson & Johnson
Novartis International AG
AbbVie
Pfizer Inc.
Sanofi S.A.
EMD Serono
Gilead Sciences Inc.
Prometheus Therapeutics & Diagnostics
Aduro BioTech
Galena Biopharma
Bavarian Nordic
Celldex Therapeutics
ImmunoCellular Therapeutics
Incyte
Market segment by Type, the product can be split into
Immune Checkpoint Inhibitors
Monoclonal Antibodies
Cytokine-Based Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy
Market segment by Application, split into
Hospitals
Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Immuno-Oncology status, future forecast, growth opportunity, key market and key players.
To present the Immuno-Oncology development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Immuno-Oncology are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immuno-Oncology Market Size Growth Rate by Type (2014-2025)
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Monoclonal Antibodies
1.4.4 Cytokine-Based Immunotherapy
1.4.5 Cancer Vaccines
1.4.6 CAR-T Cell Therapy
1.5 Market by Application
1.5.1 Global Immuno-Oncology Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Immuno-Oncology Market Size
2.2 Immuno-Oncology Growth Trends by Regions
2.2.1 Immuno-Oncology Market Size by Regions (2014-2025)
2.2.2 Immuno-Oncology Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Immuno-Oncology Market Size by Manufacturers
3.1.1 Global Immuno-Oncology Revenue by Manufacturers (2014-2019)
3.1.2 Global Immuno-Oncology Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
3.2 Immuno-Oncology Key Players Head office and Area Served
3.3 Key Players Immuno-Oncology Product/Solution/Service
3.4 Date of Enter into Immuno-Oncology Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Immuno-Oncology Market Size by Type (2014-2019)
4.2 Global Immuno-Oncology Market Size by Application (2014-2019)
5 United States
5.1 United States Immuno-Oncology Market Size (2014-2019)
5.2 Immuno-Oncology Key Players in United States
5.3 United States Immuno-Oncology Market Size by Type
5.4 United States Immuno-Oncology Market Size by Application
6 Europe
6.1 Europe Immuno-Oncology Market Size (2014-2019)
6.2 Immuno-Oncology Key Players in Europe
6.3 Europe Immuno-Oncology Market Size by Type
6.4 Europe Immuno-Oncology Market Size by Application
7 China
7.1 China Immuno-Oncology Market Size (2014-2019)
7.2 Immuno-Oncology Key Players in China
7.3 China Immuno-Oncology Market Size by Type
7.4 China Immuno-Oncology Market Size by Application
8 Japan
8.1 Japan Immuno-Oncology Market Size (2014-2019)
8.2 Immuno-Oncology Key Players in Japan
8.3 Japan Immuno-Oncology Market Size by Type
8.4 Japan Immuno-Oncology Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Immuno-Oncology Market Size (2014-2019)
9.2 Immuno-Oncology Key Players in Southeast Asia
9.3 Southeast Asia Immuno-Oncology Market Size by Type
9.4 Southeast Asia Immuno-Oncology Market Size by Application
10 India
10.1 India Immuno-Oncology Market Size (2014-2019)
10.2 Immuno-Oncology Key Players in India
10.3 India Immuno-Oncology Market Size by Type
10.4 India Immuno-Oncology Market Size by Application
11 Central & South America
11.1 Central & South America Immuno-Oncology Market Size (2014-2019)
11.2 Immuno-Oncology Key Players in Central & South America
11.3 Central & South America Immuno-Oncology Market Size by Type
11.4 Central & South America Immuno-Oncology Market Size by Application
12 International Players Profiles
12.1 Amgen, Inc
12.1.1 Amgen, Inc Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immuno-Oncology Introduction
12.1.4 Amgen, Inc Revenue in Immuno-Oncology Business (2014-2019)
12.1.5 Amgen, Inc Recent Development
12.2 AstraZeneca, Plc
12.2.1 AstraZeneca, Plc Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immuno-Oncology Introduction
12.2.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2014-2019)
12.2.5 AstraZeneca, Plc Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immuno-Oncology Introduction
12.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2014-2019)
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Celgene Corporation
12.4.1 Celgene Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immuno-Oncology Introduction
12.4.4 Celgene Corporation Revenue in Immuno-Oncology Business (2014-2019)
12.4.5 Celgene Corporation Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immuno-Oncology Introduction
12.5.4 Eli Lilly and Company Revenue in Immuno-Oncology Business (2014-2019)
12.5.5 Eli Lilly and Company Recent Development
12.6 Merck & Co.
12.6.1 Merck & Co. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immuno-Oncology Introduction
12.6.4 Merck & Co. Revenue in Immuno-Oncology Business (2014-2019)
12.6.5 Merck & Co. Recent Development
12.7 Hoffmann-La Roche AG
12.7.1 Hoffmann-La Roche AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Immuno-Oncology Introduction
12.7.4 Hoffmann-La Roche AG Revenue in Immuno-Oncology Business (2014-2019)
12.7.5 Hoffmann-La Roche AG Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Company Details
12.8.2 Company Description and Business Overview
12.8.3 Immuno-Oncology Introduction
12.8.4 Johnson & Johnson Revenue in Immuno-Oncology Business (2014-2019)
12.8.5 Johnson & Johnson Recent Development
12.9 Novartis International AG
12.9.1 Novartis International AG Company Details
12.9.2 Company Description and Business Overview
12.9.3 Immuno-Oncology Introduction
12.9.4 Novartis International AG Revenue in Immuno-Oncology Business (2014-2019)
12.9.5 Novartis International AG Recent Development
12.10 AbbVie
12.10.1 AbbVie Company Details
12.10.2 Company Description and Business Overview
12.10.3 Immuno-Oncology Introduction
12.10.4 AbbVie Revenue in Immuno-Oncology Business (2014-2019)
12.10.5 AbbVie Recent Development
12.11 Pfizer Inc.
12.12 Sanofi S.A.
12.13 EMD Serono
12.14 Gilead Sciences Inc.
12.15 Prometheus Therapeutics & Diagnostics
12.16 Aduro BioTech
12.17 Galena Biopharma
12.18 Bavarian Nordic
12.19 Celldex Therapeutics
12.20 ImmunoCellular Therapeutics
12.21 Incyte
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Immuno-Oncology Key Market Segments
Table Key Players Immuno-Oncology Covered
Table Global Immuno-Oncology Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Immuno-Oncology Market Size Market Share by Type 2014-2025
Figure Immune Checkpoint Inhibitors Figures
Table Key Players of Immune Checkpoint Inhibitors
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Cytokine-Based Immunotherapy Figures
Table Key Players of Cytokine-Based Immunotherapy
Figure Cancer Vaccines Figures
Table Key Players of Cancer Vaccines
Figure CAR-T Cell Therapy Figures
Table Key Players of CAR-T Cell Therapy
Table Global Immuno-Oncology Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Immuno-Oncology Report Years Considered
Table Global Immuno-Oncology Market Size 2014-2025 (Million US$)
Figure Global Immuno-Oncology Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Immuno-Oncology Market Size by Regions 2014-2025 (Million US$)
Table Global Immuno-Oncology Market Size by Regions 2014-2019 (Million US$)
Table Global Immuno-Oncology Market Share by Regions 2014-2019
Figure Global Immuno-Oncology Market Share by Regions 2014-2019
Figure Global Immuno-Oncology Market Share by Regions 2019
Table Market Top Trends
Table Global Immuno-Oncology Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Immuno-Oncology Market Share by Manufacturers (2014-2019)
Figure Global Immuno-Oncology Market Share by Manufacturers in 2018
Table Global Immuno-Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Immuno-Oncology Product/Solution/Service
Table Date of Enter into Immuno-Oncology Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
Table Global Immuno-Oncology Market Size Share by Type (2014-2019)
Figure Global Immuno-Oncology Market Size Market Share by Type (2014-2019)
Table Global Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
Table Global Immuno-Oncology Market Size Share by Application (2014-2019)
Figure Global Immuno-Oncology Market Size Market Share by Application (2014-2019)
Figure Global Immuno-Oncology Revenue Market Share by Application in 2018
Figure United States Immuno-Oncology Market Size 2014-2019 (Million US$)
Table United States Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
Table United States Key Players Immuno-Oncology Market Share (2018-2019)
Table United States Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
Table United States Immuno-Oncology Market Share by Type (2014-2019)
Table United States Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
Table United States Immuno-Oncology Market Share by Application (2014-2019)
Figure Europe Immuno-Oncology Market Size 2014-2019 (Million US$)
Table Europe Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
Table Europe Key Players Immuno-Oncology Market Share (2018-2019)
Table Europe Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
Table Europe Immuno-Oncology Market Share by Type (2014-2019)
Table Europe Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
Table Europe Immuno-Oncology Market Share by Application (2014-2019)
Figure China Immuno-Oncology Market Size 2014-2019 (Million US$)
Table China Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
Table China Key Players Immuno-Oncology Market Share (2018-2019)
Table China Immuno-Oncology Market Size by Type (2014-20189) (Million US$)
Table China Immuno-Oncology Market Share by Type (2014-2019)
Table China Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
Table China Immuno-Oncology Market Share by Application (2014-2019)
Figure Japan Immuno-Oncology Market Size 2014-2019 (Million US$)
Table Japan Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
Table Japan Key Players Immuno-Oncology Market Share (2018-2019)
Table Japan Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
Table Japan Immuno-Oncology Market Share by Type (2014-2019)
Table Japan Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
Table Japan Immuno-Oncology Market Share by Application (2014-2019)
Figure Southeast Asia Immuno-Oncology Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Immuno-Oncology Market Share (2018-2019)
Table Southeast Asia Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Immuno-Oncology Market Share by Type (2014-2019)
Table Southeast Asia Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Immuno-Oncology Market Share by Application (2014-2019)
Figure India Immuno-Oncology Market Size 2014-2019 (Million US$)
Table India Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
Table India Key Players Immuno-Oncology Market Share (2018-2019)
Table India Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
Table India Immuno-Oncology Market Share by Type (2014-2019)
Table India Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
Table India Immuno-Oncology Market Share by Application (2014-2019)
Figure Central & South America Immuno-Oncology Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Immuno-Oncology Market Share (2018-2019)
Table Central & South America Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
Table Central & South America Immuno-Oncology Market Share by Type (2014-2019)
Table Central & South America Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
Table Central & South America Immuno-Oncology Market Share by Application (2014-2019)
Table Amgen, Inc Company Details
Table Amgen, Inc Revenue in Immuno-Oncology Business (2014-2019) (Million US$)
Figure Amgen, Inc Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table Amgen, Inc Recent Development
Table AstraZeneca, Plc Company Details
Table AstraZeneca, Plc Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table AstraZeneca, Plc Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Celgene Corporation Company Details
Table Celgene Corporation Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure Celgene Corporation Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table Celgene Corporation Recent Development
Table Eli Lilly and Company Company Details
Table Eli Lilly and Company Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure Eli Lilly and Company Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table Eli Lilly and Company Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure Merck & Co. Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table Merck & Co. Recent Development
Table Hoffmann-La Roche AG Company Details
Table Hoffmann-La Roche AG Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure Hoffmann-La Roche AG Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table Hoffmann-La Roche AG Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Novartis International AG Company Details
Table Novartis International AG Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure Novartis International AG Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table Novartis International AG Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
Table AbbVie Recent Development
Table Pfizer Inc. Company Details
Table Sanofi S.A. Company Details
Table EMD Serono Company Details
Table Gilead Sciences Inc. Company Details
Table Prometheus Therapeutics & Diagnostics Company Details
Table Aduro BioTech Company Details
Table Galena Biopharma Company Details
Table Bavarian Nordic Company Details
Table Celldex Therapeutics Company Details
Table ImmunoCellular Therapeutics Company Details
Table Incyte Company Details
Table Global Immuno-Oncology Market Size by Regions (Million US$) 2019-2025
Figure Global Immuno-Oncology Market Size Share by Regions (2019-2025)
Figure Global Immuno-Oncology Market Size Share by Regions in 2025
Figure United States Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Europe Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
Figure China Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Japan Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
Figure India Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
Table Global Immuno-Oncology Market Size by Product (2019-2025) (Million US$)
Figure Global Immuno-Oncology Market Size by Product (2019-2025)
Figure Global Immuno-Oncology Market Size by Product in 2025
Table Global Immuno-Oncology Market Size by Application (2019-2025) (Million US$)
Figure Global Immuno-Oncology Market Size by Application (2019-2025)
Figure Global Immuno-Oncology Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の免疫腫瘍アッセイキット市場：専門的調査 Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoin…- 世界の免疫腫瘍アッセイキット市場：専門的調査 Immuno-Oncology Assays Accelerate Cancer Immunotherapy enable fast, effective, and clinically relevant understanding of immuno-oncology targets, pathways and mechanisms, enabling quicker development of immuno-oncology drugs. Learn how you can rapidly screen and develop antibodies targeting checkpoin…
- 乳がんモノクローナル抗体の世界市場：市場規模・現状・予測 Breast cancer is characterized by the malignancy of cells in the tissues of the breast. HER-2 breast cancer is the most common type of breast cancer. The HER-2 protein, present on the surface of normal breast cells, affects the growth of the malignant cells. The uncontrolled synthesis of this protei…
- がんモノクローナル抗体の世界市場：インサイト・予測 The mAbs, which are produced by genetic engineering, target antigens in cells, tissues, and organs. They are used in clinical applications to treat diseases with excellent efficacy and minimal side effects. Their MOA, absence of generic pathway, and therapeutic applications distinguish them from oth…
- 膵臓癌治療の世界市場：市場規模・現状・予測 Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …